pharm-stream-recent-webinars
-
Reducing Particulate-Related Batch Risk In Bioprocessing
7/1/2026
Increasing scrutiny around particulate contamination is pushing teams to act earlier. Understanding where risks originate and applying proactive strategies can ease challenges across production.
-
How To Reduce Waste And Improve Line Efficiency
6/25/2026
False rejects signal correctable issues, not unavoidable outcomes. Learn how system setup, environment, and operational factors influence performance and how adjustments can improve yield.
-
Global Regulatory Compliance For Aseptic Barrier Systems
6/24/2026
Reconcile differing regulatory philosophies in sterile manufacturing. Learn to use prescriptive baselines and scientific data to achieve global compliance.
- Automating cell therapy manufacturing without redesigning established workflow 6/24/2026
-
Automating Cell Therapy Manufacturing Without Redesigning Workflows
6/23/2026
Cell therapy manufacturing teams face mounting pressure to automate without disrupting workflows. Learn how incremental automation can preserve process integrity and reduce risk.
-
How Intensified Upstream Processing Improves Scale-Up And Tech Transfer
6/22/2026
Intensified upstream processing can improve scalability and maintain quality. Learn how automation, PAT, and data-driven control strategies help modernize workflows and support consistent performance.
-
Generate Stable High-Producing Clones In 14 Weeks
6/18/2026
Rising complexity is putting pressure on cell line development. Discover a streamlined approach that enables rapid generation of stable clones with strong titers and long-term consistency.
-
Creative Chromatography Solutions For Complex Small Molecules
6/18/2026
Chromatographic modeling enables smarter purification. Discover how digital tools, fraction mapping, and expert execution can improve yield for the most challenging small-molecule separations.
-
Solving Formulation Challenges Across Modalities
6/15/2026
Optimize drug delivery by leveraging advanced nanoparticle engineering to dramatically increase small-molecule oral drug loading and enable ultra-high-concentration subcutaneous formulations.
-
Using Residual DNA Quantification Data To De-Risk mAb Development
6/11/2026
Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.